A Phase 3 Randomized Open Label Study to Compare NKTR-214 Combined with Nivolumab to the Investigator's Choice of Sunitinib or Cabozantinib in Patients with Previously Untreated Advanced Renal Cell Carcinoma

  • Gurney, Howard (Primary Chief Investigator)
  • Chapman, Nicola, (Research Coordinator)
  • Butala, Radhika, (Research Coordinator)

Project: OtherSponsored clinical trial

StatusActive
Effective start/end date28/02/1927/02/24